| Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements ARC Wong, JS Pearson, MD Bright, D Munera, KS Robinson, SF Lee, ... Molecular microbiology 80 (6), 1420-1438, 2011 | 389 | 2011 |
| Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements ARC Wong, JS Pearson, MD Bright, D Munera, KS Robinson, SF Lee, ... Molecular microbiology 80 (6), 1420-1438, 2011 | 389 | 2011 |
| A type III effector antagonizes death receptor signalling during bacterial gut infection JS Pearson, C Giogha, SY Ong, CL Kennedy, M Kelly, KS Robinson, ... Nature 501 (7466), 247-251, 2013 | 278 | 2013 |
| The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65 HJ Newton, JS Pearson, L Badea, M Kelly, M Lucas, G Holloway, ... PLoS pathogens 6 (5), e1000898, 2010 | 257 | 2010 |
| EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ... Nature microbiology 2 (4), 1-10, 2017 | 175 | 2017 |
| EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ... Nature microbiology 2 (4), 1-10, 2017 | 175 | 2017 |
| Flexible usage and interconnectivity of diverse cell death pathways protect against intracellular infection M Doerflinger, Y Deng, P Whitney, R Salvamoser, S Engel, AJ Kueh, L Tai, ... Immunity 53 (3), 533-547. e7, 2020 | 109 | 2020 |
| Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants DJ Ingle, M Tauschek, DJ Edwards, DM Hocking, DJ Pickard, ... Nature microbiology 1 (2), 1-9, 2016 | 80 | 2016 |
| The Genetics of Enteropathogenic Escherichia coli Virulence JS Pearson, C Giogha, T Wong Fok Lung, EL Hartland Annual review of genetics 50, 493-513, 2016 | 78 | 2016 |
| Host cell death responses to non-typhoidal Salmonella infection MA Wemyss, JS Pearson Frontiers in immunology 10, 468270, 2019 | 64 | 2019 |
| Inhibition of death receptor signaling by bacterial gut pathogens C Giogha, TWF Lung, JS Pearson, EL Hartland Cytokine & growth factor reviews 25 (2), 235-243, 2014 | 54 | 2014 |
| Salmonella effectors SseK1 and SseK3 target death domain proteins in the TNF and TRAIL signaling pathways*[S] JPM Newson, NE Scott, IYW Chung, TWF Lung, C Giogha, J Gan, ... Molecular & Cellular Proteomics 18 (6), 1138-1156, 2019 | 51 | 2019 |
| The Escherichia coli effector EspJ blocks Src kinase activity via amidation and ADP ribosylation JC Young, A Clements, AE Lang, JA Garnett, D Munera, A Arbeloa, ... Nature Communications 5 (1), 5887, 2014 | 45 | 2014 |
| Evolutionary dynamics of multidrug resistant Salmonella enterica serovar 4,[5],12:i:- in Australia DJ Ingle, RL Ambrose, SL Baines, S Duchene, A Gonçalves da Silva, ... Nature Communications 12 (1), 4786, 2021 | 44 | 2021 |
| The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation SL Vijayaraj, R Feltham, M Rashidi, D Frank, Z Liu, DS Simpson, G Ebert, ... Nature Communications 12 (1), 2713, 2021 | 44 | 2021 |
| The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection MA Pallett, CN Berger, JS Pearson, EL Hartland, G Frankel Infection and immunity 82 (11), 4878-4888, 2014 | 44 | 2014 |
| Distinct roles of the antiapoptotic effectors NleB and NleF from enteropathogenic Escherichia coli GL Pollock, CVL Oates, C Giogha, T Wong Fok Lung, SY Ong, ... Infection and immunity 85 (4), 10.1128/iai. 01071-16, 2017 | 38 | 2017 |
| The Inflammatory Response during Enterohemorrhagic Escherichia coli Infection JS Pearson, EL Hartland Enterohemorrhagic Escherichia coli and Other Shiga Toxin‐Producing E. coli …, 2015 | 37 | 2015 |
| Down the rabbit hole: Is necroptosis truly an innate response to infection? JS Pearson, JM Murphy Cellular Microbiology 19 (8), e12750, 2017 | 34 | 2017 |
| The diverse roles of RIP kinases in host-pathogen interactions VV Eng, MA Wemyss, JS Pearson Seminars in cell & developmental biology 109, 125-143, 2021 | 30 | 2021 |
